Related references
Note: Only part of the references are listed.A 5-Year Open-Label Follow-up of a Randomized Double-Blind Placebo-Controlled Trial of Intralymphatic Immunotherapy for Birch and Grass Allergy Reveals Long-term Beneficial Effects
E. Hjalmarsson et al.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2023)
High dose pollen intralymphatic immunotherapy: Two RDBPC trials question the benefit of dose increase
Laila Hellkvist et al.
ALLERGY (2022)
Intralymphatic immunotherapy with one or two allergens renders similar clinical response in patients with allergic rhinitis due to birch and grass pollen
Lars Ahlbeck et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2022)
Allergen immunotherapy for allergic airway diseases: Use lessons from the past to design a brighter future
Laura Hesse et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Intralymphatic immunotherapy improves grass pollen allergic rhinoconjunctivitis: A 3-year randomized placebo-controlled trial
Soren Helbo Skaarup et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Mechanisms of Allergen Immunotherapy in Allergic Rhinitis
Gabija Drazdauskaite et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2021)
Intralymphatic immunotherapy for allergic rhinitis: A systematic review and meta-analysis
Michael T. Werner et al.
ALLERGY AND ASTHMA PROCEEDINGS (2021)
HealthSWEDE: costs with sublingual immunotherapy-a Swedish questionnaire study
Petter Olsson et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2021)
Intralymphatic immunotherapy in pollen-allergic young adults with rhinoconjunctivitis and mild asthma: A randomized trial
Jon R. Konradsen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Cost-effectiveness of grass pollen allergen immunotherapy in adults
Danilo Di Bona et al.
ALLERGY (2020)
Mechanisms of Subcutaneous and updates Sublingual Aeroallergen Immunotherapy: What Is New?
Zsolt Istvan Komlosi et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2020)
A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy
Dan Weinfeld et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2020)
Intralymphatic Immunotherapy: Update and Unmet Needs
Gabriela Senti et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)
Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass: A randomized, double-blind, placebo-controlled trial
Laila Hellkvist et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Intralymphatic allergen immunotherapy against pollen allergy A 3-year open follow-up study of 10 patients
Lars Ahlbeck et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis
G. Roberts et al.
ALLERGY (2018)
Novel approaches and perspectives in allergen immunotherapy
H. J. Hoffmann et al.
ALLERGY (2017)
Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper
O. Pfaar et al.
ALLERGY (2017)
Three-injection intralymphatic immunotherapy in adolescents and young adults with grass pollen rhinoconjunctivitis
Amber M. Patterson et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2016)
TOTALL: high cost of allergic rhinitis-a national Swedish population-based questionnaire study
Lars-Olaf Cardell et al.
NPJ PRIMARY CARE RESPIRATORY MEDICINE (2016)
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies
M. A. Calderon et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2016)
Intralymphatic immunotherapy induces allergen specific plasmablasts and increases tolerance to skin prick testing in a pilot study
Johannes Martin Schmid et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2016)
Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement
Marek L. Kowalski et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2016)
Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial
Terese Hylander et al.
RESPIRATORY RESEARCH (2016)
Adverse Events During Immunotherapy Against Grass Pollen-Induced Allergic Rhinitis - Differences Between Subcutaneous and Sublingual Treatment
Kristian Aasbjerg et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2015)
The minimally important difference in the Rhinoconjunctivitis Total Symptom Score in grass-pollen-induced allergic rhinoconjunctivitis
P. Devillier et al.
ALLERGY (2014)
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper
O. Pfaar et al.
ALLERGY (2014)
Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?
Marianne Witten et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Intralymphatic allergen-specific immunotherapy: An effective and safe alternative treatment route for pollen-induced allergic rhinitis
Terese Hylander et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergy
M. Schiappoli et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial
Gabriela Senti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Allergen-induced cytokine secretion in atopic and non-atopic asthmatic children
MF Böttcher et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2003)
Share Paper
